124 related articles for article (PubMed ID: 7776826)
1. A novel class of potent tetrahydrocannabinols (THCS): 2'-yne-delta 8- and delta 9-THCS.
Ryan W; Singer M; Razdan RK; Compton DR; Martin BR
Life Sci; 1995; 56(23-24):2013-20. PubMed ID: 7776826
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological evaluation of halogenated delta 8-THC analogs.
Charalambous A; Lin S; Marciniak G; Banijamali A; Friend FL; Compton DR; Martin BR; Makriyannis A
Pharmacol Biochem Behav; 1991 Nov; 40(3):509-12. PubMed ID: 1666915
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of agonist-antagonist properties of nitrogen mustard and cyano derivatives of delta 8-tetrahydrocannabinol.
Wiley JL; Compton DR; Gordon PM; Siegel C; Singer M; Dutta A; Lichtman AH; Balster RL; Razdan RK; Martin BR
Neuropharmacology; 1996; 35(12):1793-804. PubMed ID: 9076759
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological evaluation of dimethylheptyl analogs of delta 9-THC: reassessment of the putative three-point cannabinoid-receptor interaction.
Martin BR; Compton DR; Prescott WR; Barrett RL; Razdan RK
Drug Alcohol Depend; 1995 Mar; 37(3):231-40. PubMed ID: 7796717
[TBL] [Abstract][Full Text] [Related]
5. Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol.
Compton DR; Gold LH; Ward SJ; Balster RL; Martin BR
J Pharmacol Exp Ther; 1992 Dec; 263(3):1118-26. PubMed ID: 1335057
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents.
Compton DR; Johnson MR; Melvin LS; Martin BR
J Pharmacol Exp Ther; 1992 Jan; 260(1):201-9. PubMed ID: 1309872
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and pharmacological evaluation of ether and related analogues of delta 8-, delta 9-, and delta 9,11-tetrahydrocannabinol.
Compton DR; Prescott WR; Martin BR; Siegel C; Gordon PM; Razdan RK
J Med Chem; 1991 Nov; 34(11):3310-6. PubMed ID: 1659638
[TBL] [Abstract][Full Text] [Related]
8. Variation of the alkyl side chain in delta 8-THC.
Huffman JW; Lainton JA; Dai D; Jordan RD; Duncan SG
Life Sci; 1995; 56(23-24):2021-4. PubMed ID: 7776827
[TBL] [Abstract][Full Text] [Related]
9. Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs.
Martin BR; Compton DR; Thomas BF; Prescott WR; Little PJ; Razdan RK; Johnson MR; Melvin LS; Mechoulam R; Ward SJ
Pharmacol Biochem Behav; 1991 Nov; 40(3):471-8. PubMed ID: 1666911
[TBL] [Abstract][Full Text] [Related]
10. Separation of cannabinoid receptor affinity and efficacy in delta-8-tetrahydrocannabinol side-chain analogues.
Griffin G; Williams S; Aung MM; Razdan RK; Martin BR; Abood ME
Br J Pharmacol; 2001 Jan; 132(2):525-35. PubMed ID: 11159703
[TBL] [Abstract][Full Text] [Related]
11. Importance of the C-1 substituent in classical cannabinoids to CB2 receptor selectivity: synthesis and characterization of a series of O,2-propano-delta 8-tetrahydrocannabinol analogs.
Reggio PH; Wang T; Brown AE; Fleming DN; Seltzman HH; Griffin G; Pertwee RG; Compton DR; Abood ME; Martin BR
J Med Chem; 1997 Sep; 40(20):3312-8. PubMed ID: 9379452
[TBL] [Abstract][Full Text] [Related]
12. Paradoxical pharmacological effects of deoxy-tetrahydrocannabinol analogs lacking high CB1 receptor affinity.
Wiley JL; Jefferson RG; Griffin G; Liddle J; Yu S; Huffman JW; Martin BR
Pharmacology; 2002 Oct; 66(2):89-99. PubMed ID: 12207116
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological evaluation of iodo and nitro analogs of delta 8-THC and delta 9-THC.
Martin BR; Compton DR; Semus SF; Lin S; Marciniak G; Grzybowska J; Charalambous A; Makriyannis A
Pharmacol Biochem Behav; 1993 Oct; 46(2):295-301. PubMed ID: 8265683
[TBL] [Abstract][Full Text] [Related]
14. Novel pyrazole cannabinoids: insights into CB(1) receptor recognition and activation.
Wiley JL; Jefferson RG; Grier MC; Mahadevan A; Razdan RK; Martin BR
J Pharmacol Exp Ther; 2001 Mar; 296(3):1013-22. PubMed ID: 11181936
[TBL] [Abstract][Full Text] [Related]
15. Stereochemical effects of 11-OH-delta 8-THC-dimethylheptyl in mice and dogs.
Little PJ; Compton DR; Mechoulam R; Martin BR
Pharmacol Biochem Behav; 1989 Mar; 32(3):661-6. PubMed ID: 2544901
[TBL] [Abstract][Full Text] [Related]
16. Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception.
Welch SP; Dunlow LD; Patrick GS; Razdan RK
J Pharmacol Exp Ther; 1995 Jun; 273(3):1235-44. PubMed ID: 7791096
[TBL] [Abstract][Full Text] [Related]
17. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.
Smith PB; Compton DR; Welch SP; Razdan RK; Mechoulam R; Martin BR
J Pharmacol Exp Ther; 1994 Jul; 270(1):219-27. PubMed ID: 8035318
[TBL] [Abstract][Full Text] [Related]
18. AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in Mice.
Wiley JL; Marusich JA; Lefever TW; Antonazzo KR; Wallgren MT; Cortes RA; Patel PR; Grabenauer M; Moore KN; Thomas BF
J Pharmacol Exp Ther; 2015 Sep; 354(3):328-39. PubMed ID: 26105953
[TBL] [Abstract][Full Text] [Related]
19. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study.
Oviedo A; Glowa J; Herkenham M
Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs.
Adams IB; Ryan W; Singer M; Thomas BF; Compton DR; Razdan RK; Martin BR
J Pharmacol Exp Ther; 1995 Jun; 273(3):1172-81. PubMed ID: 7791088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]